| Kimberly Lynn Zambito, MD | |
|
2501 Kuser Rd Ste 3, Hamilton, NJ 08691-3386 | |
| (609) 896-0444 | |
| (609) 896-2617 |
| Full Name | Kimberly Lynn Zambito |
|---|---|
| Gender | Female |
| Speciality | Hand Surgery |
| Experience | 22 Years |
| Location | 2501 Kuser Rd Ste 3, Hamilton, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306038880 | NPI | - | NPPES |
| 1024280500001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XS0106X | Orthopaedic Surgery - Hand Surgery | MD434044 (Pennsylvania) | Primary |
| 207XS0106X | Orthopaedic Surgery - Hand Surgery | 25MA09793200 (New Jersey) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Warren Hospital | Phillipsburg, NJ | Hospital |
| St Lukes Quakertown Hospital | Quakertown, PA | Hospital |
| St Luke's Hospital Bethlehem | Bethlehem, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Luke's Physician Group Inc | 6709798333 | 1739 |
| St Lukes Warren Physician Group Pc | 9739093675 | 314 |
News Archive
Conservatives in the House have pressured Speaker John Boehner, R-Ohio, to advance their goal of defunding the health law, and criticized Senate cosnervative colleagues for caving on the issue. There are also threats of filibuster and concerns about the impact this strategy could have on the Republican party.
The Associated Press/The Boston Globe reports on Karen Fennell, a lobbyist who lacks the typical "fat expense account and clients paying six-figure fees," but has still managed to secure "some coveted federal money" for her clients: birthing centers. "How she did it is a case study in how Washington's influence game can work, even for those without bottomless checkbooks. She cultivated key allies in Congress, crafted an argument that aligns with the prevailing political winds, and represents a constituency no lawmaker could shun: mothers-to-be."
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its drug candidate, SPX-106, achieved statistically significant reductions in triglycerides and cholesterol when administered in combination with D-tagatose for nine weeks to genetically engineered mice prone to dyslipidemia.
An evaluation of 203 women as part of the multifaceted Los Angeles Atherosclerosis Study (LAAS) found that those who transitioned more quickly through menopause were at increased risk for a higher rate of progression of "preclinical atherosclerosis" - narrowing of arteries caused by the thickening of their walls.
› Verified 7 days ago
| Entity Name | Mercer Bucks Orthopaedics P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801843511 PECOS PAC ID: 0042116345 Enrollment ID: O20031209000224 |
News Archive
Conservatives in the House have pressured Speaker John Boehner, R-Ohio, to advance their goal of defunding the health law, and criticized Senate cosnervative colleagues for caving on the issue. There are also threats of filibuster and concerns about the impact this strategy could have on the Republican party.
The Associated Press/The Boston Globe reports on Karen Fennell, a lobbyist who lacks the typical "fat expense account and clients paying six-figure fees," but has still managed to secure "some coveted federal money" for her clients: birthing centers. "How she did it is a case study in how Washington's influence game can work, even for those without bottomless checkbooks. She cultivated key allies in Congress, crafted an argument that aligns with the prevailing political winds, and represents a constituency no lawmaker could shun: mothers-to-be."
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its drug candidate, SPX-106, achieved statistically significant reductions in triglycerides and cholesterol when administered in combination with D-tagatose for nine weeks to genetically engineered mice prone to dyslipidemia.
An evaluation of 203 women as part of the multifaceted Los Angeles Atherosclerosis Study (LAAS) found that those who transitioned more quickly through menopause were at increased risk for a higher rate of progression of "preclinical atherosclerosis" - narrowing of arteries caused by the thickening of their walls.
› Verified 7 days ago
| Entity Name | St Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700984622 PECOS PAC ID: 6709798333 Enrollment ID: O20040226000062 |
News Archive
Conservatives in the House have pressured Speaker John Boehner, R-Ohio, to advance their goal of defunding the health law, and criticized Senate cosnervative colleagues for caving on the issue. There are also threats of filibuster and concerns about the impact this strategy could have on the Republican party.
The Associated Press/The Boston Globe reports on Karen Fennell, a lobbyist who lacks the typical "fat expense account and clients paying six-figure fees," but has still managed to secure "some coveted federal money" for her clients: birthing centers. "How she did it is a case study in how Washington's influence game can work, even for those without bottomless checkbooks. She cultivated key allies in Congress, crafted an argument that aligns with the prevailing political winds, and represents a constituency no lawmaker could shun: mothers-to-be."
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its drug candidate, SPX-106, achieved statistically significant reductions in triglycerides and cholesterol when administered in combination with D-tagatose for nine weeks to genetically engineered mice prone to dyslipidemia.
An evaluation of 203 women as part of the multifaceted Los Angeles Atherosclerosis Study (LAAS) found that those who transitioned more quickly through menopause were at increased risk for a higher rate of progression of "preclinical atherosclerosis" - narrowing of arteries caused by the thickening of their walls.
› Verified 7 days ago
| Entity Name | Tps Iv Of Pa, L.l.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740248905 PECOS PAC ID: 4183685308 Enrollment ID: O20041021000401 |
News Archive
Conservatives in the House have pressured Speaker John Boehner, R-Ohio, to advance their goal of defunding the health law, and criticized Senate cosnervative colleagues for caving on the issue. There are also threats of filibuster and concerns about the impact this strategy could have on the Republican party.
The Associated Press/The Boston Globe reports on Karen Fennell, a lobbyist who lacks the typical "fat expense account and clients paying six-figure fees," but has still managed to secure "some coveted federal money" for her clients: birthing centers. "How she did it is a case study in how Washington's influence game can work, even for those without bottomless checkbooks. She cultivated key allies in Congress, crafted an argument that aligns with the prevailing political winds, and represents a constituency no lawmaker could shun: mothers-to-be."
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its drug candidate, SPX-106, achieved statistically significant reductions in triglycerides and cholesterol when administered in combination with D-tagatose for nine weeks to genetically engineered mice prone to dyslipidemia.
An evaluation of 203 women as part of the multifaceted Los Angeles Atherosclerosis Study (LAAS) found that those who transitioned more quickly through menopause were at increased risk for a higher rate of progression of "preclinical atherosclerosis" - narrowing of arteries caused by the thickening of their walls.
› Verified 7 days ago
| Entity Name | Gslpg, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366006702 PECOS PAC ID: 7810226875 Enrollment ID: O20190917001763 |
News Archive
Conservatives in the House have pressured Speaker John Boehner, R-Ohio, to advance their goal of defunding the health law, and criticized Senate cosnervative colleagues for caving on the issue. There are also threats of filibuster and concerns about the impact this strategy could have on the Republican party.
The Associated Press/The Boston Globe reports on Karen Fennell, a lobbyist who lacks the typical "fat expense account and clients paying six-figure fees," but has still managed to secure "some coveted federal money" for her clients: birthing centers. "How she did it is a case study in how Washington's influence game can work, even for those without bottomless checkbooks. She cultivated key allies in Congress, crafted an argument that aligns with the prevailing political winds, and represents a constituency no lawmaker could shun: mothers-to-be."
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its drug candidate, SPX-106, achieved statistically significant reductions in triglycerides and cholesterol when administered in combination with D-tagatose for nine weeks to genetically engineered mice prone to dyslipidemia.
An evaluation of 203 women as part of the multifaceted Los Angeles Atherosclerosis Study (LAAS) found that those who transitioned more quickly through menopause were at increased risk for a higher rate of progression of "preclinical atherosclerosis" - narrowing of arteries caused by the thickening of their walls.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kimberly Lynn Zambito, MD 2501 Kuser Rd Ste 3, Hamilton, NJ 08691-3386 Ph: (609) 896-0444 | Kimberly Lynn Zambito, MD 2501 Kuser Rd Ste 3, Hamilton, NJ 08691-3386 Ph: (609) 896-0444 |
News Archive
Conservatives in the House have pressured Speaker John Boehner, R-Ohio, to advance their goal of defunding the health law, and criticized Senate cosnervative colleagues for caving on the issue. There are also threats of filibuster and concerns about the impact this strategy could have on the Republican party.
The Associated Press/The Boston Globe reports on Karen Fennell, a lobbyist who lacks the typical "fat expense account and clients paying six-figure fees," but has still managed to secure "some coveted federal money" for her clients: birthing centers. "How she did it is a case study in how Washington's influence game can work, even for those without bottomless checkbooks. She cultivated key allies in Congress, crafted an argument that aligns with the prevailing political winds, and represents a constituency no lawmaker could shun: mothers-to-be."
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its drug candidate, SPX-106, achieved statistically significant reductions in triglycerides and cholesterol when administered in combination with D-tagatose for nine weeks to genetically engineered mice prone to dyslipidemia.
An evaluation of 203 women as part of the multifaceted Los Angeles Atherosclerosis Study (LAAS) found that those who transitioned more quickly through menopause were at increased risk for a higher rate of progression of "preclinical atherosclerosis" - narrowing of arteries caused by the thickening of their walls.
› Verified 7 days ago
Scott D Miller, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3705 Quakerbridge Road, Suite 103, Hamilton, NJ 08619 Phone: 609-394-3804 Fax: 609-989-1550 | |
Dr. Fredric Kleinbart, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2501 Kuser Rd Ste 3, Hamilton, NJ 08691 Phone: 609-896-0444 Fax: 609-896-2617 | |
Francis Cyran, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2501 Kuser Rd Ste 3, Hamilton, NJ 08691 Phone: 609-896-0444 Fax: 609-896-0444 | |
Dr. Paul W. Codjoe, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2501 Kuser Rd Ste 3, Hamilton, NJ 08691 Phone: 609-896-0444 Fax: 609-896-2617 | |
David Paul Hardeski, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2501 Kuser Rd, Hamilton, NJ 08691 Phone: 609-587-4777 | |
Dr. Thomas J. Capotosta, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2501 Kuser Rd, Hamilton, NJ 08691 Phone: 609-587-4777 Fax: 609-587-4349 |